Technique for analyzing specific T-cell responses could pave way for more rationally designed vaccines

Immunology: Personalized vaccines edge closer
Vaccines against rotavirus (pictured) are still ineffective for vast swathes of the world’s population. Credit: CDC/Erskine Palmer

Among different populations, a vaccine can vary in efficacy against a specific pathogen. Unraveling the discrepancy requires tools to analyze the exact nature of responses by a specific type of immune cell: the T cell. Now, a research team from Singapore and the United States has developed an approach that simultaneously identifies and characterizes T cells specific to a variety of antigens—the part of the pathogen recognized by the immune system. The work could lead to more personalized and thus effective vaccine designs.

"[Our] approach can be applied to the study of any vaccine that elicits a T-, allowing for an in-depth analysis of the breadth and quality of the antigen-specific T-cell response," says Evan Newell of the A*STAR Singapore Immunology Network, who led the study.

The new method involves a combination of two technologies. First, complexes of candidate peptide antigens and major histocompatibility complex (MHC) molecules, which bind antigens for presentation to T cells, are each tagged with a unique combination of heavy metal markers. These so-called 'tetramers' are then incubated with patient samples containing T cells, which attach to any complexes with that match those recognized by receptors on the T-. Next, a high-throughput, multiplexing technique called mass cytometry is used to analyze the coupled T cells at single-cell resolution. "This yields an unprecedented amount of information from each sample," says Newell.

As a proof of principle, Newell and his co-workers analyzed blood and from healthy volunteers for T cells that recognize rotavirus (see image). "Rotavirus infection is a major problem in the developing world, partially because vaccines do not work well there," explains Newell. The gut pathogen causes severe diarrhea in young children and kills more than 500,000 people worldwide each year.

The researchers stained the T cells from the healthy individuals with a series of 77 candidate rotavirus epitopes. Each epitope is a slightly different site on a rotavirus protein—the antigen—that is recognized by the immune system. From this larger collection, they identified and validated six rotavirus epitopes and simultaneously analyzed the T cells specific for each of them.

"We were surprised to find that T cells targeting different parts of the rotavirus had dramatically different characteristics; and, only one set of these T cells were found to be present in the intestine of normal donors," says Newell. "These analyses should allow faster identification of correlates for vaccine efficacy that can be used to speed the testing of new vaccines," he adds.

More information: Newell, E. et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization, Nature Biotechnology 31, 623–629 (2013). www.nature.com/nbt/journal/v31… 7/full/nbt.2593.html

add to favorites email to friend print save as pdf

Related Stories

Engineered rice protects against rotavirus infection

Aug 08, 2013

For children and immune compromised adults in developing countries, diarrheal disease induced by rotavirus can be life threatening. Current rotaviral vaccines are highly effective in the Western world, but are not as effective ...

Rotavirus vaccine given to newborns in Africa is effective

Jun 17, 2013

Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration. ...

Recommended for you

Developing 'tissue chip' to screen neurological toxins

20 minutes ago

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that ...

Gene mutation discovered in blood disorder

4 hours ago

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which ...

Airway muscle-on-a-chip mimics asthma

6 hours ago

The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people ...

Lost protein could prevent hardening of the arteries

10 hours ago

(Medical Xpress)—Researchers have found that when the protein matrix metalloproteinase-14 (MMP-14) is reduced or lost, white blood cells, known as macrophages, become good and could prevent hardening of ...

User comments